2-methyl-3-[5-(substituted phenyl) - Δ2 -triazoline] - 4 - (3H)- quinazolinones as potential cardiovascular agents

Indian Drugs

Volumn 35, Issue 5, 1998, Pages 261-265

  Kumar, Ashok ^a   Tyagi, Ritu ^a   Bansal, Ekta ^a   Verma, R S ^a   Saxena, K K ^a   Srivastava, V K ^a  

^a LLRM MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL [3 IMINO(2 FLUOROPHENYL)] 4,(3H) QUINAZOLINONE; QUINAZOLINONE DERIVATIVE; TRIAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR DISEASE; CAT; DRUG ACTIVITY; DRUG EFFICACY; DRUG ISOLATION; DRUG POTENCY; FEMALE; LD 50; MALE; NONHUMAN;

EID: 0031800730     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Kumar P., Nath C., Bhargava K. P. and Shanker K.: Pharmazie, 1982, H. 11, 802.
2. Goodman L. S. and Gilman A.: "The pharmacological basis of Therapeutics", 1985, 7th ed. Collier MacMillan, London.
3. Gupta D. P., Ahmad S., Kumar A. and Shanker K.: Ind. J. Chem., 1988, 27B (II)a, 1060-1062.
4. Kumar A., Gurtu S., Sinha J. N., Bhargava K. P. and Shanker K.: Eur. J. Med. Chem. 1985, 20(i), 95-96.
5. Hess H. J., Cronin T. H. and Scriabine A.:J. Med. Chem., 1968, 11, 130.
6. Hayao. S., Avera J. H., Strycker W. O., Leipizig T. J., Kulpand R. A., Hartzer H. E.: J. Med. Chem., 1965, 8, 807.
7. Takahasti T., Sugimole H.: Jpn. Kokai, 196, 76, 82285.
8. BrogdonR. N., Heil R. C., Speight T. M. and Avery G. S.: Drugs, 1977, 14, 163.
9. Kumar A., Gupta S., Saxena K. K., Srivastava V. K., Verma R. S. and Bajpai S. K.: Pak. J. Sci. and Res. (In Press) 1996.
10. Tyagi R., Verma R. S., Srivastava V. K. and Kumar A.:Eur. J. Med. Chem. (Communicated 1997).
11. Kumar A., Saxena K. K., Srivastava V. K., Lata S. and Saxena R. S.:J. Indian Chem. Soc., 1991, 68, 138-141.
12. Triwedi P. B., Undavia N. K., Dave A. M., Bhatt K. N. and Desai N. C.: Ind. J. Chem. 1993, 32B, 760-765.
13. Smith C. C.:J. Pharmacol. Exp. Therp., 1950, 100, 408.